| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.2 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |